A detailed history of Advisor Group Holdings, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 18,744 shares of BBIO stock, worth $444,607. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,744
Previous 19,788 5.28%
Holding current value
$444,607
Previous $501,000 4.79%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.91 - $31.3 $24,962 - $32,677
-1,044 Reduced 5.28%
18,744 $477,000
Q2 2024

Aug 13, 2024

BUY
$23.0 - $31.04 $44,114 - $59,534
1,918 Added 10.73%
19,788 $501,000
Q1 2024

May 10, 2024

BUY
$27.35 - $40.45 $55,356 - $81,870
2,024 Added 12.77%
17,870 $552,000
Q4 2023

Feb 12, 2024

BUY
$24.02 - $43.89 $324,005 - $592,032
13,489 Added 572.3%
15,846 $639,000
Q3 2023

Nov 13, 2023

BUY
$16.89 - $35.01 $2,263 - $4,691
134 Added 6.03%
2,357 $62,000
Q2 2023

Aug 10, 2023

BUY
$13.29 - $18.01 $2,365 - $3,205
178 Added 8.7%
2,223 $38,000
Q1 2023

May 12, 2023

BUY
$7.17 - $18.55 $1,684 - $4,359
235 Added 12.98%
2,045 $33,000
Q4 2022

Feb 10, 2023

SELL
$6.74 - $11.52 $303 - $518
-45 Reduced 2.43%
1,810 $13,000
Q3 2022

Nov 14, 2022

SELL
$7.94 - $12.36 $682 - $1,062
-86 Reduced 4.43%
1,855 $18,000
Q2 2022

Aug 10, 2022

BUY
$5.21 - $12.14 $687 - $1,602
132 Added 7.3%
1,941 $18,000
Q1 2022

May 04, 2022

SELL
$7.34 - $17.16 $1,453 - $3,397
-198 Reduced 9.87%
1,809 $18,000
Q2 2021

Aug 02, 2021

BUY
$46.47 - $63.93 $15,846 - $21,800
341 Added 20.47%
2,007 $122,000
Q1 2021

May 13, 2021

SELL
$55.47 - $72.35 $6,767 - $8,826
-122 Reduced 6.82%
1,666 $102,000
Q4 2020

Feb 10, 2021

BUY
$38.38 - $71.11 $18,537 - $34,346
483 Added 37.01%
1,788 $127,000
Q2 2020

Aug 14, 2020

BUY
$22.22 - $35.69 $10,554 - $16,952
475 Added 57.23%
1,305 $43,000
Q1 2020

May 18, 2020

BUY
$16.11 - $36.23 $13,371 - $30,070
830 New
830 $24,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.52B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.